Skip to content
Screener

Net Income at other companies

BK
BKBK
$1.63B+33.8%
BK
BKBK
$1.63B+33.8%
Veradermics logo
VeradermicsMANE
-$27.23M-120%
GPA
General Purpose Acquisition Corp.GPAC
-$5.23M-37.4%
GPA
General Purpose Acquisition Corp.GPAC
-$5.23M-37.4%
Polaryx Therapeutics, Inc. logo
Polaryx Therapeutics, Inc.PLYX
-$2.54M+49.6%

Where this comes from

Reported directly by First Tracks Biotherapeutics Inc in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The source filing: First Tracks Biotherapeutics Inc’s 10-Q, filed May 14, 2026. Open the filing →

Filed
May 14, 2026, 4:32 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-224190

FAQ

What is First Tracks Biotherapeutics Inc's net income?
First Tracks Biotherapeutics Inc (TRAX) reported net income of -$50.48M in Q1 2026.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

Ask your AI about First Tracks Biotherapeutics Inc's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude